Patient 2 was characterized as having the highest combined expression of oestrogen receptor (ER) plus PR, with positive expression of Her2/neu in the ductal component of the breast carcinoma, that was classified as Luminal A. The gene discussed is ERBB2; the disease is breast carcinoma.